Virological failure after 1 year of first-line ART is not associated with HIV minority drug resistance in rural Cameroon
Author(s) -
Alexander Zoufaly,
Johannes Jochum,
Raffaela Hammerl,
Nilofar Nassimi,
Yurika Raymond,
Gerd Burchard,
Stefan Schmiedel,
Jan Felix Drexler,
N. K. Campbell,
Nchang Taka,
Charles Awasom,
Karin J. Metzner,
Jan van Lunzen,
Torsten Feldt
Publication year - 2014
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dku470
Subject(s) - medicine , human immunodeficiency virus (hiv) , drug resistance , hiv drug resistance , antiretroviral therapy , sida , drug , viral load , virology , viral disease , pharmacology , biology , microbiology and biotechnology
The aim of this study was to describe clinical and virological outcomes in therapy-naive HIV-1-positive patients treated in a routine ART programme in rural Cameroon.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom